NAs monotherapy group

DRUG2 trials

Sponsors

Qing XIe, xieqing

Conditions

Chronic Hepatitis b

Unknown Phase

Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study）

RecruitingNCT06323681

Qing XIeChronic Hepatitis b

Start: 2024-02-04End: 2027-08-31Target: 2016Updated: 2024-03-21

A Study on the Pursuit of Sustained Clearance of HBsAg in Chronic Hepatitis B(CHB) Patients With Previous Interferon Treatment Using Pegylated Interferon Alpha

Not yet recruitingNCT07537387

xieqingChronic Hepatitis b

Start: 2026-04-30End: 2030-12-31Target: 10000Updated: 2026-04-17